Raghava Gollapudi is a Cardiology physician affiliated with Radiance Technologies. OpenAlex indexes 13 publications with 1,600 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3131 Berger Ave
Suite 200
San Diego, CA 921234233
Telephone
858-244-6865Registry record last updated 29 Dec 2014.
Industry payments
54 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Edwards Lifesciences CorporationProgram year202515 payments
- Boston Scientific CorporationProgram year20254 payments
- Shockwave Medical, IncProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78%Beta blocker16.8%Metoprolol Succinate35%Metoprolol Tartrate34%Carvedilol22%Atenolol9%Part D<11 patientsStatin14.7%Atorvastatin Calcium84%Rosuvastatin Calcium16%Part D≥57 patients+ 12 more classes in this area
Blood & clotting
20.1%P2Y12 inhibitor12.5%Clopidogrel74%Brilinta26%Part D≥47 patientsFactor Xa inhibitor6.6%Eliquis100%Part D≥32 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.9%Potassium supplement1.9%Potassium Chloride100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Percutaneous Repair of Postoperative Mitral Regurgitation After Left Ventricular Assist Device Implant
The Annals of Thoracic Surgery
2018 - Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Theophilus Owan, MD
Radiance Technologies
Edward Portnay, MD
Radiance Technologies
Judith Veis, MD
Radiance Technologies
Abhilash Akinapelli, MD
Radiance Technologies
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”